Johnson & Johnson today reported fourth quarter results that beat The Street on sales but only matched on earnings.

J&J grows MedTech sales 6.1% in 2025, driven by cardiovascular and surgical products, and advances its robotic surgical ...

Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

Edge Medical highlighted a growing wave of startups using technology to delay kidney failure and improve dialysis clinic ...

Innovators who holistically develop their products, studies, and payment strategy with these things in mind will reduce risks ...

New report analyzes digital demand, growth trends, and competitive dynamics across the healthcare and medical technology sector. Seattle, ...

FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL ...

MDO's 2026 Leadership in Medtech issue features J&J MedTech's Tim Schmid, serial entrepreneur Ray Cohen, Intuitive's Darla ...

Johnson & Johnson (JNJ) stock slips after the company's Q4 2025 earnings which beat on the topline but stood in line with the ...

In May 2025, DP World signed a historic agreement with the Dominican government to expand the Port of Caucedo and the adjacent Free Trade Zone, increasing terminal handling capacity and developing 225 ...